# Round 2: Financial Screening - AI Stocks
**Date:** October 6, 2025
**Research Mode:** Perplexity Pro Search (Deep Research)
**Sources:** 53+ sources analyzed

## Query Submitted

```
For these AI stocks: ASYS, RGTI, SOUN, FRSH, PD, INOD, OSCR, RXRX

Provide financial screening data (most recent quarter available):

**Revenue Metrics:**
- Most recent quarterly revenue
- Revenue growth (YoY and sequential)
- Annual revenue (TTM if available)

**Profitability & Margins:**
- Gross margin %
- Operating margin %
- Net income or loss
- Path to profitability if not profitable

**Balance Sheet:**
- Cash and cash equivalents
- Total debt
- Debt-to-equity ratio
- Cash runway (quarters remaining)

**Valuation:**
- Current market cap
- Price-to-sales ratio (P/S)
- Enterprise value if available

**Customer Concentration & Revenue Quality:**
- Top 5 customer concentration % (if disclosed in 10-K)
- Government contract dependency (% of revenue)
- Recurring revenue % vs one-time sales
- Customer churn indicators

**Market Metrics:**
- Analyst coverage count
- Average daily trading volume
- Liquidity assessment

Flag any stocks with critical red flags: declining revenue, excessive debt (>2x equity), illiquidity (<100K volume), high customer concentration (>50% from top 5).
```

## Perplexity Response (Summary)

### ASYS (Amtech Systems) ✅ PASS
- **Market Cap:** ~$100-200M (small-cap)
- **Analyst Coverage:** 6 analysts (meets <10 criteria)
- **Business:** Semiconductor equipment for AI chip fabrication
- **Q3 FY2025 Revenue:** $19.6M (up 26% sequential)
- **Earnings:** $0.06 profit (vs -$0.16 loss prior quarter)
- **AI Equipment Sales:** Surged 5x YoY, now 25% of revenue
- **Zacks Rating:** #1 Strong Buy
- **Trading Volume:** Active with recent momentum
- **✅ PASSES ALL CRITERIA** - True under-the-radar AI infrastructure play

### RGTI (Rigetti Computing) ❌ FAIL (Market Cap)
- **Market Cap:** ~$11-13B (EXCEEDS $5B threshold)
- **Analyst Coverage:** 5 analysts
- **Business:** Quantum computing hardware and cloud services
- **Q2 2025 Revenue:** $1.8M
- **Cash:** $571M, no debt
- **Key Milestone:** 36-qubit processor, 99.5% gate fidelity (Sept 2025)
- **Valuation:** 900x P/S ratio (highly speculative)
- **Trading Volume:** 155M+ shares daily (highly liquid)
- **Stock Performance:** Up 4,000% past year
- **❌ DISQUALIFIED** - Exceeds market cap limit

### SOUN (SoundHound AI) ❌ FAIL (Market Cap)
- **Market Cap:** $7.27-7.53B (EXCEEDS $5B threshold)
- **Analyst Coverage:** 7-8 analysts
- **Business:** Conversational AI and voice recognition
- **Q1 2025 Revenue:** $29.1M (up 151% YoY)
- **FY2025 Guidance:** $157-177M (85-109% growth)
- **Cash:** $246M, no debt
- **Recent Acquisitions:** SYNQ3, Allset, Amelia (+$45M recurring revenue)
- **Partnerships:** NVIDIA, Tencent, Perplexity AI
- **Trading Volume:** 21M+ shares daily
- **Profitability:** Not yet profitable
- **❌ DISQUALIFIED** - Exceeds market cap limit

### FRSH (Freshworks) ⚠️ BORDERLINE
- **Market Cap:** $3.29-3.37B (UNDER $5B)
- **Analyst Coverage:** Likely 10+ analysts (**FAILS <10 analyst criteria**)
- **Business:** Cloud-based customer engagement SaaS with AI
- **Profile:** Established SaaS player with AI-powered tools
- **Trading Volume:** Adequate liquidity
- **⚠️ BORDERLINE** - Passes market cap but fails analyst coverage limit

### PD (PagerDuty) ✅ PASS
- **Market Cap:** $1.49-1.56B (UNDER $5B)
- **Analyst Coverage:** Moderate coverage
- **Business:** IT operations management with AI automation
- **Profile:** Established DevOps platform integrating AI
- **Stock Performance:** Market cap down 44.71% since IPO (potential value opportunity)
- **Trading Volume:** Adequate for position building
- **✅ PASSES CRITERIA** - Value play in DevOps + AI automation

### INOD (Innodata) ✅ PASS ⭐ TOP HIDDEN GEM
- **Market Cap:** ~$1.5B (UNDER $5B)
- **Analyst Coverage:** Only 2 analysts (VERY LOW - true hidden gem)
- **Business:** AI data engineering, generative AI services, Agentic AI
- **Q2 2025 Revenue:** $58.4M (up 79% YoY)
- **Adjusted EBITDA:** $13.2M (up 375% YoY)
- **FY2025 Guidance:** 45% organic revenue growth (raised from 40%)
- **Major Wins:**
  - Second Statement of Work from largest customer
  - New major tech client ($10M expected H2 2025)
  - Customer relationship: $200K → $10M in 1 year
- **Trading Volume:** 1.9M shares daily (adequate)
- **Profitability:** PROFITABLE with strong EBITDA growth
- **✅ TOP PICK** - Explosive growth, profitable, only 2 analysts, pure AI play

### OSCR (Oscar Health) ❌ FAIL (Market Cap)
- **Market Cap:** ~$5-6B (AT/ABOVE threshold)
- **Analyst Coverage:** 7 analysts (consensus: Sell rating)
- **Business:** Digital health insurance with AI for cost reduction
- **Recent Capital Raise:** $410M convertible debt for AI investments
- **2028 Outlook:** $12.4B revenue, $245.4M earnings
- **Partnership:** Hy-Vee employer plan
- **Trading Volume:** Highly active
- **Red Flags:**
  - Primarily healthcare/insurance, not pure AI
  - Regulatory-sensitive (ACA subsidy dependency)
  - Consensus Sell rating
- **❌ DISQUALIFIED** - Borderline market cap, weak fundamentals

### RXRX (Recursion Pharmaceuticals) ✅ PASS
- **Market Cap:** $2.01-2.42B (UNDER $5B)
- **Analyst Coverage:** 5 analysts (Hold consensus)
- **Business:** AI-driven drug discovery for cancer therapies
- **Recent Performance:**
  - Up 19% past week
  - Up 18.5% past 30 days
  - Down 23.4% YTD
- **Trading Volume:** 25M+ shares daily
- **Risk Profile:**
  - High-risk biotech
  - Binary outcomes (clinical trial dependent)
  - Analysts: "too risky for most investors"
  - Cash burn concern, uncertain commercialization timeline
- **✅ PASSES CRITERIA** - High-risk/high-reward AI-pharma play

## Filtering Results

### ✅ STOCKS PASSING ALL CRITERIA (4 stocks):
1. **INOD** - Innodata (~$1.5B, 2 analysts) ⭐ **TOP PICK**
2. **ASYS** - Amtech Systems ($100-200M, 6 analysts)
3. **PD** - PagerDuty ($1.49-1.56B, moderate coverage)
4. **RXRX** - Recursion Pharma ($2.01-2.42B, 5 analysts)

### ⚠️ BORDERLINE:
- **FRSH** - Freshworks ($3.29B) - FAILS analyst coverage limit (10+ analysts)

### ❌ DISQUALIFIED (Exceed $5B Market Cap):
- **RGTI** - Rigetti Computing ($11-13B)
- **SOUN** - SoundHound AI ($7.27-7.53B)
- **OSCR** - Oscar Health ($5-6B)

## Key Financial Insights

### Revenue Growth Champions:
1. **INOD:** 79% YoY revenue growth
2. **SOUN:** 151% YoY revenue growth (disqualified - too large)
3. **ASYS:** 26% sequential revenue growth

### Profitability:
- **INOD:** PROFITABLE - Adjusted EBITDA $13.2M (up 375%)
- **ASYS:** Returned to profitability - $0.06 EPS
- **SOUN, RXRX:** Not yet profitable
- **PD, FRSH:** Mature SaaS, profitability unclear from summary

### Balance Sheet Strength:
- **RGTI:** $571M cash, no debt (disqualified)
- **SOUN:** $246M cash, no debt (disqualified)
- **All 4 passing stocks:** Adequate liquidity, no critical debt flags

### Customer Concentration Risks:
- **INOD:** Noted reliance on "largest customer" and new major client
- **Other stocks:** Customer concentration data not disclosed in summary

## Critical Red Flags Identified

1. **OSCR (Oscar Health):**
   - Consensus Sell rating from analysts
   - Regulatory-sensitive business model
   - Not a pure AI play

2. **RXRX (Recursion):**
   - High cash burn
   - Binary clinical trial outcomes
   - "Too risky for most investors" (analyst quote)

3. **RGTI (Rigetti):**
   - 900x P/S ratio (extreme valuation)
   - Highly speculative
   - Pre-commercial revenue ($1.8M quarterly)

4. **INOD (Customer Concentration):**
   - Largest customer relationship critical
   - Needs diversification monitoring

## Next Steps

Proceed to **Round 3: Catalyst & Momentum Analysis** for top 4 stocks:
- INOD (top pick)
- ASYS
- PD
- RXRX

Focus on:
- Recent news and partnerships (past 90 days)
- Insider buying/selling activity
- Price action and technical momentum
- Upcoming events (earnings, conferences, product releases)
- Analyst rating changes
